Actelion Pharmaceuticals Ltd
AddressActelion Pharmaceuticals Ltd
Actelion is a biopharmaceutical company headquartered in Allschwil / Basel, Switzerland.
Actelion's first drug, Tracleer, is a therapy for pulmonary arterial hypertonia-approved dual endothelin receptor antagonist in Tablet form. Actelion distributes Tracleer through its own offices in the major international markets, so the United States (based in South San Francisco), the European Union, Japan, Canada, Australia and the USA Switzerland. Actelion, founded in 1997, is a leading global company the exploration of the endothelium. The endothelium separates the vessel wall from the Bloodstream.
Actelion is focused on delivering innovative medicines in areas with high medical needs to be developed, developed and marketed.
Data Source: HELP.CH your e-guide ®